Key Insights

Highlights

Success Rate

67% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 62/100

Termination Rate

10.0%

2 terminated out of 20 trials

Success Rate

66.7%

-19.8% vs benchmark

Late-Stage Pipeline

5%

1 trials in Phase 3/4

Results Transparency

25%

1 of 4 completed with results

Key Signals

1 with results67% success

Data Visualizations

Phase Distribution

15Total
Not Applicable (11)
P 1 (1)
P 2 (2)
P 4 (1)

Trial Status

Recruiting6
Active Not Recruiting4
Completed4
Terminated2
Unknown2
Withdrawn2

Trial Success Rate

66.7%

Benchmark: 86.5%

Based on 4 completed trials

Clinical Trials (20)

Showing 20 of 20 trials
NCT06590285Not ApplicableRecruiting

Diagnostic Refinement and Educational Approaches in Managing Bone Marrow Transplantation

NCT06541002Not ApplicableRecruiting

A Novel Digital Application (SHIFT) to Improve Outcomes for Hematopoietic Stem Cell Transplant Survivors

NCT06910969Not ApplicableRecruitingPrimary

Multidisciplinary Intervention for Adults With Chronic Graft-versus-host Disease

NCT03865589Not ApplicableActive Not RecruitingPrimary

Using Ultrasound Elastography to Predict Development of Hepatic Sinusoidal Obstruction Syndrome

NCT05709912Not ApplicableActive Not RecruitingPrimary

Mobile CARE-App to Promote Coping for Caregivers of Patients Receiving Stem Cell Transplant

NCT06472089Not ApplicableRecruitingPrimary

BMT-CARE: Psychosocial Intervention for Transplant Caregivers

NCT05611307Terminated

Late Subclinical Cardiovascular Disease in Testicular Cancer Survivors

NCT05629676Not ApplicableActive Not RecruitingPrimary

Virtual Reality Intervention for Patients Undergoing BMT

NCT05316740Active Not RecruitingPrimary

Vaginal Microbiome and the Development of Vulvovaginal Graft Versus Host Disease

NCT03858530Not ApplicableTerminatedPrimary

Ultrasound Elastography to Predict Development of SOS

NCT06416761Recruiting

Genetics in the Progression of Nephropathies

NCT05895201Phase 1WithdrawnPrimary

High-Dose Post-Transplant Cyclophosphamide, Bortezomib, and Sitagliptin for the Prevention of GVHD

NCT05352789Completed

Nutrition and Metabolic Prehabilitation in HSCT Patients UK and ROI. BSBMT Multi-centre Survey.

NCT03200626Completed

Observational Study to Evaluate Hematopoietic Progenitor Cell Mobilization in Patients With Newly Diagnosed Multiple Myeloma

NCT05694910Not ApplicableUnknownPrimary

Reiki Effects on Bone Marrow Transplant Patients

NCT05175222Not ApplicableCompleted

Assessment of Efficacy of LightWalker (Nd:Yag, Er:Yag) Laser Therapy on Incidence, Severity and Duration of Oral Mucositis in Patients Undergoing Hematopoietic Stem Cell Transplantation (HSCT). Prospective Randomized Open-label Study

NCT04313036Phase 2Unknown

5-day Defibrotide Treatment for Hepatic SOS/VOD

NCT04687982Not ApplicableCompleted

Feasibility and Efficacy of Modified Donor Lymphocytes Infusion (CD45RA Negative Selected) After Haploidentical Transplantation With Post-transplantation Cyclophosphamide in Patients With Hematological Malignancies (ONC-2016-002).

NCT03963999Phase 4Withdrawn

Validating Ultrasound Biomarkers for Hepatic Sinusoidal Obstruction Syndrome in Pediatric Hematopoietic Cell Transplant Patients

NCT03818334Phase 2RecruitingPrimary

Post Transplant Cyclophosphamide in Matched Unrelated Donor Stem Cell Transplantation for Hematological Malignancies

Showing all 20 trials

Research Network

Activity Timeline